Newborn Screening
0
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
IlluminaCA - Hayward
1 programnewborn genetic screening and whole genome sequencingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
Illuminanewborn genetic screening and whole genome sequencing
Clinical Trials (1)
Total enrollment: 20,000 patients across 1 trials
Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project
Start: Dec 2024Est. completion: Dec 202620,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 20,000 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.